Patent · US Active

Anti-CD40 antibodies for use in treatment of Sjögren's syndrome

US12065499B2 · kind B2 · utility

0Cited by
5References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 1, 2018
Grant dateAug 20, 2024
Priority date—
Expiry dateAug 8, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/94
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The disclosure relates to methods, treatment regimens, uses, kits and therapies for treating Sjögren's syndrome, by employing anti-CD40 antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.